Eli Lilly and Co. announced the U.S. Food and Drug Administration (FDA) approved Foundayo (orforglipron) for adults with obesity, or overweight with weight-related medical problems. This could mark a significant milestone for dairy processors seeking to provide products for those taking GLP-1 receptor agonists. Lilly has submitted orforglipron for weight management and/or type 2 diabetes in more than 40 countries and plans to launch in each country, it says.

Smearcase founders Drew DiSpirito and Joe Rotondo join Dairy Foods for Episode 63 of the “Let’s Talk Dairy” podcast, where they discuss Smearcase and frozen cottage cheese (FroCo). During this podcast, DiSpirito discusses the origin of Smearcase and why and how it processes frozen cottage cheese, ways Smearcase differentiates itself from the competition, and more.

Chobani announced a $567 million expansion of its Michigan La Colombe plant, that is expected to add over 200,000 square feet of production space and nearly 340 new jobs, while retaining 312 jobs. La Colombe first started in Philadelphia in 1994, making crafted coffee in cafés across the country. In 2016, the brand launched its signature ready-to-drink lattes, bringing the coffeehouse experience into hands across the country.